GOOD NEWS ON COVID-19 FRONT
Closing in on COVID Vaccines Source: European Commission President Ursula Von Der Leyen & Council President Charles Michel EU Historic Stimulus Package Researchers at Oxford University in the UK, along with AstraZeneca, have developed a COVID vaccine that is proving to be successful at building immunity against COVID. Human trials on more than 1000 patients have proven the vaccine effective. The vaccine has moved into combined Phase 2 and Phase 3 trials - the last stop to prove it works. AstraZeneca has a $1.2 billion deal with the US to deliver 300 million doses this fall, if the vaccine is approved. Two More Vaccines Meanwhile, at Moderna Pharma in Cambridge, MA, an experimental mRNA vaccine is in human trials and it is proving to be effective. It has produced antibodies in all the patients involved in the trials And, in China biotech Cansino's vaccine is showing positive antibody responses in a Phase 2 trial. It is entering Phase 3 ...